0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Coronary Stent System Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-28G15196
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Eluting Coronary Stent System Market Research Report 2023
BUY CHAPTERS

Global Drug Eluting Coronary Stent System Market Research Report 2024

Code: QYRE-Auto-28G15196
Report
November 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Coronary Stent System Market Size

The global market for Drug Eluting Coronary Stent System was valued at US$ 5690 million in the year 2023 and is projected to reach a revised size of US$ 7655 million by 2030, growing at a CAGR of 4.3% during the forecast period.

Drug Eluting Coronary Stent System Market

Drug Eluting Coronary Stent System Market

The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
North American market for Drug Eluting Coronary Stent System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Eluting Coronary Stent System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drug Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Coronary Stent System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Coronary Stent System.
The Drug Eluting Coronary Stent System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Eluting Coronary Stent System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Coronary Stent System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Coronary Stent System Market Report

Report Metric Details
Report Name Drug Eluting Coronary Stent System Market
Accounted market size in year US$ 5690 million
Forecasted market size in 2030 US$ 7655 million
CAGR 4.3%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, LifeTech Scientific Corporation, MicroPort Scientific Corporation, Yilson Medical Technology, Lepu Medical Technology, Shandong Hua'an Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Coronary Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Coronary Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Eluting Coronary Stent System Market growing?

Ans: The Drug Eluting Coronary Stent System Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Drug Eluting Coronary Stent System Market size in 2030?

Ans: The Drug Eluting Coronary Stent System Market size in 2030 will be US$ 7655 million.

Who are the main players in the Drug Eluting Coronary Stent System Market report?

Ans: The main players in the Drug Eluting Coronary Stent System Market are Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, LifeTech Scientific Corporation, MicroPort Scientific Corporation, Yilson Medical Technology, Lepu Medical Technology, Shandong Hua'an Biotechnology

What are the Application segmentation covered in the Drug Eluting Coronary Stent System Market report?

Ans: The Applications covered in the Drug Eluting Coronary Stent System Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Drug Eluting Coronary Stent System Market report?

Ans: The Types covered in the Drug Eluting Coronary Stent System Market report are Rapamycin Eluting Stent, Everolimus Eluting Stent, Others

Recommended Reports

Coronary Stent Systems

Drug Eluting Devices

Vascular & Medical Stents

1 Drug Eluting Coronary Stent System Market Overview
1.1 Product Definition
1.2 Drug Eluting Coronary Stent System by Type
1.2.1 Global Drug Eluting Coronary Stent System Market Value Comparison by Type (2024-2030)
1.2.2 Rapamycin Eluting Stent
1.2.3 Everolimus Eluting Stent
1.2.4 Others
1.3 Drug Eluting Coronary Stent System by Application
1.3.1 Global Drug Eluting Coronary Stent System Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Drug Eluting Coronary Stent System Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Coronary Stent System Revenue 2019-2030
1.4.2 Global Drug Eluting Coronary Stent System Sales 2019-2030
1.4.3 Global Drug Eluting Coronary Stent System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Coronary Stent System Market Competition by Manufacturers
2.1 Global Drug Eluting Coronary Stent System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Coronary Stent System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Coronary Stent System Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Drug Eluting Coronary Stent System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Enter into This Industry
2.8 Global Drug Eluting Coronary Stent System Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Coronary Stent System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Coronary Stent System Players Market Share by Revenue
2.8.3 Global Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Coronary Stent System Market Scenario by Region
3.1 Global Drug Eluting Coronary Stent System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Coronary Stent System Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Coronary Stent System Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Coronary Stent System Sales by Region: 2025-2030
3.3 Global Drug Eluting Coronary Stent System Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Coronary Stent System Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Coronary Stent System Revenue by Region: 2025-2030
3.4 North America Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.4.1 North America Drug Eluting Coronary Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Coronary Stent System Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Coronary Stent System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Coronary Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Coronary Stent System Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Coronary Stent System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Coronary Stent System Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Coronary Stent System Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Coronary Stent System Sales by Region (2019-2030)
3.6.3 Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Coronary Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Coronary Stent System Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Coronary Stent System Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Coronary Stent System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Coronary Stent System Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Coronary Stent System Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Coronary Stent System Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Coronary Stent System Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Coronary Stent System Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Coronary Stent System Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Coronary Stent System Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Coronary Stent System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Coronary Stent System Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Coronary Stent System Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Coronary Stent System Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Coronary Stent System Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Coronary Stent System Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Coronary Stent System Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Coronary Stent System Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Coronary Stent System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Drug Eluting Coronary Stent System Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Drug Eluting Coronary Stent System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Drug Eluting Coronary Stent System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B.Braun Drug Eluting Coronary Stent System Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BD Drug Eluting Coronary Stent System Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Biotronik AG
6.6.1 Biotronik AG Company Information
6.6.2 Biotronik AG Description and Business Overview
6.6.3 Biotronik AG Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biotronik AG Drug Eluting Coronary Stent System Product Portfolio
6.6.5 Biotronik AG Recent Developments/Updates
6.7 Stentys SA
6.7.1 Stentys SA Company Information
6.7.2 Stentys SA Description and Business Overview
6.7.3 Stentys SA Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Stentys SA Drug Eluting Coronary Stent System Product Portfolio
6.7.5 Stentys SA Recent Developments/Updates
6.8 Sino Medical
6.8.1 Sino Medical Company Information
6.8.2 Sino Medical Description and Business Overview
6.8.3 Sino Medical Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sino Medical Drug Eluting Coronary Stent System Product Portfolio
6.8.5 Sino Medical Recent Developments/Updates
6.9 Beijing ESSEN Technology
6.9.1 Beijing ESSEN Technology Company Information
6.9.2 Beijing ESSEN Technology Description and Business Overview
6.9.3 Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing ESSEN Technology Drug Eluting Coronary Stent System Product Portfolio
6.9.5 Beijing ESSEN Technology Recent Developments/Updates
6.10 Beijing Advanced Medical Technologies
6.10.1 Beijing Advanced Medical Technologies Company Information
6.10.2 Beijing Advanced Medical Technologies Description and Business Overview
6.10.3 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product Portfolio
6.10.5 Beijing Advanced Medical Technologies Recent Developments/Updates
6.11 LifeTech Scientific Corporation
6.11.1 LifeTech Scientific Corporation Company Information
6.11.2 LifeTech Scientific Corporation Description and Business Overview
6.11.3 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product Portfolio
6.11.5 LifeTech Scientific Corporation Recent Developments/Updates
6.12 MicroPort Scientific Corporation
6.12.1 MicroPort Scientific Corporation Company Information
6.12.2 MicroPort Scientific Corporation Description and Business Overview
6.12.3 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product Portfolio
6.12.5 MicroPort Scientific Corporation Recent Developments/Updates
6.13 Yilson Medical Technology
6.13.1 Yilson Medical Technology Company Information
6.13.2 Yilson Medical Technology Description and Business Overview
6.13.3 Yilson Medical Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yilson Medical Technology Drug Eluting Coronary Stent System Product Portfolio
6.13.5 Yilson Medical Technology Recent Developments/Updates
6.14 Lepu Medical Technology
6.14.1 Lepu Medical Technology Company Information
6.14.2 Lepu Medical Technology Description and Business Overview
6.14.3 Lepu Medical Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lepu Medical Technology Drug Eluting Coronary Stent System Product Portfolio
6.14.5 Lepu Medical Technology Recent Developments/Updates
6.15 Shandong Hua'an Biotechnology
6.15.1 Shandong Hua'an Biotechnology Company Information
6.15.2 Shandong Hua'an Biotechnology Description and Business Overview
6.15.3 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product Portfolio
6.15.5 Shandong Hua'an Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Coronary Stent System Industry Chain Analysis
7.2 Drug Eluting Coronary Stent System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Coronary Stent System Production Mode & Process
7.4 Drug Eluting Coronary Stent System Sales and Marketing
7.4.1 Drug Eluting Coronary Stent System Sales Channels
7.4.2 Drug Eluting Coronary Stent System Distributors
7.5 Drug Eluting Coronary Stent System Customers
8 Drug Eluting Coronary Stent System Market Dynamics
8.1 Drug Eluting Coronary Stent System Industry Trends
8.2 Drug Eluting Coronary Stent System Market Drivers
8.3 Drug Eluting Coronary Stent System Market Challenges
8.4 Drug Eluting Coronary Stent System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Eluting Coronary Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Drug Eluting Coronary Stent System Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Drug Eluting Coronary Stent System Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Drug Eluting Coronary Stent System Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Drug Eluting Coronary Stent System Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Drug Eluting Coronary Stent System Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Drug Eluting Coronary Stent System Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Drug Eluting Coronary Stent System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Coronary Stent System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Coronary Stent System as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Coronary Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Drug Eluting Coronary Stent System Sales by Region (2019-2024) & (K Units)
 Table 18. Global Drug Eluting Coronary Stent System Sales Market Share by Region (2019-2024)
 Table 19. Global Drug Eluting Coronary Stent System Sales by Region (2025-2030) & (K Units)
 Table 20. Global Drug Eluting Coronary Stent System Sales Market Share by Region (2025-2030)
 Table 21. Global Drug Eluting Coronary Stent System Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Drug Eluting Coronary Stent System Revenue Market Share by Region (2019-2024)
 Table 23. Global Drug Eluting Coronary Stent System Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Drug Eluting Coronary Stent System Revenue Market Share by Region (2025-2030)
 Table 25. North America Drug Eluting Coronary Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Drug Eluting Coronary Stent System Sales by Country (2019-2024) & (K Units)
 Table 27. North America Drug Eluting Coronary Stent System Sales by Country (2025-2030) & (K Units)
 Table 28. North America Drug Eluting Coronary Stent System Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Drug Eluting Coronary Stent System Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Drug Eluting Coronary Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Drug Eluting Coronary Stent System Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Drug Eluting Coronary Stent System Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Drug Eluting Coronary Stent System Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Drug Eluting Coronary Stent System Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Coronary Stent System Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Drug Eluting Coronary Stent System Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Drug Eluting Coronary Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Drug Eluting Coronary Stent System Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Drug Eluting Coronary Stent System Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Drug Eluting Coronary Stent System Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Drug Eluting Coronary Stent System Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Drug Eluting Coronary Stent System Sales (K Units) by Type (2019-2024)
 Table 51. Global Drug Eluting Coronary Stent System Sales (K Units) by Type (2025-2030)
 Table 52. Global Drug Eluting Coronary Stent System Sales Market Share by Type (2019-2024)
 Table 53. Global Drug Eluting Coronary Stent System Sales Market Share by Type (2025-2030)
 Table 54. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2019-2024)
 Table 57. Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2025-2030)
 Table 58. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Drug Eluting Coronary Stent System Sales (K Units) by Application (2019-2024)
 Table 61. Global Drug Eluting Coronary Stent System Sales (K Units) by Application (2025-2030)
 Table 62. Global Drug Eluting Coronary Stent System Sales Market Share by Application (2019-2024)
 Table 63. Global Drug Eluting Coronary Stent System Sales Market Share by Application (2025-2030)
 Table 64. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2019-2024)
 Table 67. Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2025-2030)
 Table 68. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2025-2030)
 Table 70. Boston Scientific Company Information
 Table 71. Boston Scientific Description and Business Overview
 Table 72. Boston Scientific Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Boston Scientific Drug Eluting Coronary Stent System Product
 Table 74. Boston Scientific Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Medtronic Drug Eluting Coronary Stent System Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Abbott Drug Eluting Coronary Stent System Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. B.Braun Company Information
 Table 86. B.Braun Description and Business Overview
 Table 87. B.Braun Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. B.Braun Drug Eluting Coronary Stent System Product
 Table 89. B.Braun Recent Developments/Updates
 Table 90. BD Company Information
 Table 91. BD Description and Business Overview
 Table 92. BD Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. BD Drug Eluting Coronary Stent System Product
 Table 94. BD Recent Developments/Updates
 Table 95. Biotronik AG Company Information
 Table 96. Biotronik AG Description and Business Overview
 Table 97. Biotronik AG Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Biotronik AG Drug Eluting Coronary Stent System Product
 Table 99. Biotronik AG Recent Developments/Updates
 Table 100. Stentys SA Company Information
 Table 101. Stentys SA Description and Business Overview
 Table 102. Stentys SA Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Stentys SA Drug Eluting Coronary Stent System Product
 Table 104. Stentys SA Recent Developments/Updates
 Table 105. Sino Medical Company Information
 Table 106. Sino Medical Description and Business Overview
 Table 107. Sino Medical Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Sino Medical Drug Eluting Coronary Stent System Product
 Table 109. Sino Medical Recent Developments/Updates
 Table 110. Beijing ESSEN Technology Company Information
 Table 111. Beijing ESSEN Technology Description and Business Overview
 Table 112. Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Beijing ESSEN Technology Drug Eluting Coronary Stent System Product
 Table 114. Beijing ESSEN Technology Recent Developments/Updates
 Table 115. Beijing Advanced Medical Technologies Company Information
 Table 116. Beijing Advanced Medical Technologies Description and Business Overview
 Table 117. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product
 Table 119. Beijing Advanced Medical Technologies Recent Developments/Updates
 Table 120. LifeTech Scientific Corporation Company Information
 Table 121. LifeTech Scientific Corporation Description and Business Overview
 Table 122. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 124. LifeTech Scientific Corporation Recent Developments/Updates
 Table 125. MicroPort Scientific Corporation Company Information
 Table 126. MicroPort Scientific Corporation Description and Business Overview
 Table 127. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 129. MicroPort Scientific Corporation Recent Developments/Updates
 Table 130. Yilson Medical Technology Company Information
 Table 131. Yilson Medical Technology Description and Business Overview
 Table 132. Yilson Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Yilson Medical Technology Drug Eluting Coronary Stent System Product
 Table 134. Yilson Medical Technology Recent Developments/Updates
 Table 135. Lepu Medical Technology Company Information
 Table 136. Lepu Medical Technology Description and Business Overview
 Table 137. Lepu Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Lepu Medical Technology Drug Eluting Coronary Stent System Product
 Table 139. Lepu Medical Technology Recent Developments/Updates
 Table 140. Shandong Hua'an Biotechnology Company Information
 Table 141. Shandong Hua'an Biotechnology Description and Business Overview
 Table 142. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product
 Table 144. Shandong Hua'an Biotechnology Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Drug Eluting Coronary Stent System Distributors List
 Table 148. Drug Eluting Coronary Stent System Customers List
 Table 149. Drug Eluting Coronary Stent System Market Trends
 Table 150. Drug Eluting Coronary Stent System Market Drivers
 Table 151. Drug Eluting Coronary Stent System Market Challenges
 Table 152. Drug Eluting Coronary Stent System Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Coronary Stent System
 Figure 2. Global Drug Eluting Coronary Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Drug Eluting Coronary Stent System Market Share by Type: 2023 & 2030
 Figure 4. Rapamycin Eluting Stent Product Picture
 Figure 5. Everolimus Eluting Stent Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Drug Eluting Coronary Stent System Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Drug Eluting Coronary Stent System Market Share by Application: 2023 & 2030
 Figure 9. Hospitals
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Drug Eluting Coronary Stent System Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Drug Eluting Coronary Stent System Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Drug Eluting Coronary Stent System Sales (2019-2030) & (K Units)
 Figure 15. Global Drug Eluting Coronary Stent System Average Price (US$/Unit) & (2019-2030)
 Figure 16. Drug Eluting Coronary Stent System Report Years Considered
 Figure 17. Drug Eluting Coronary Stent System Sales Share by Manufacturers in 2023
 Figure 18. Global Drug Eluting Coronary Stent System Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Drug Eluting Coronary Stent System Players: Market Share by Revenue in Drug Eluting Coronary Stent System in 2023
 Figure 20. Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Drug Eluting Coronary Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Drug Eluting Coronary Stent System Sales Market Share by Country (2019-2030)
 Figure 23. North America Drug Eluting Coronary Stent System Revenue Market Share by Country (2019-2030)
 Figure 24. United States Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Drug Eluting Coronary Stent System Sales Market Share by Country (2019-2030)
 Figure 27. Europe Drug Eluting Coronary Stent System Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Drug Eluting Coronary Stent System Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Drug Eluting Coronary Stent System Revenue Market Share by Region (2019-2030)
 Figure 35. China Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Drug Eluting Coronary Stent System Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Drug Eluting Coronary Stent System Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Drug Eluting Coronary Stent System Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Drug Eluting Coronary Stent System Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Drug Eluting Coronary Stent System by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Drug Eluting Coronary Stent System by Type (2019-2030)
 Figure 54. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Drug Eluting Coronary Stent System by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Drug Eluting Coronary Stent System by Application (2019-2030)
 Figure 57. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2019-2030)
 Figure 58. Drug Eluting Coronary Stent System Value Chain
 Figure 59. Drug Eluting Coronary Stent System Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart